The FDA has recently required the manufacturers of the drug metoclopramide, more commonly know as Reglan, to place a black box warning on its label alerting consumers of the link between the drug and a condition called tardive dyskinesia. Tardive dyskinesia is characterized by involuntary and repetitive movements of the body. A black box warning is the strongest warning that the FDA can require.

The Ford Pinto is a car that became notoriously associated with fuel-fed crash fires in the late 1960s and early 1970s, when the compact vehicle showed a propensity for catching fire when involved in even low-speed crashes. In 1977, an internal memo revealed that Ford was aware of design problems with the Pinto that made it more susceptible to crash-related fires, but that it had deemed the overall benefits of redesigning the automobile - which included preventing an average of 180 deaths each year - to be not worth the cost - an estimated $11 per automobile.

On December 11, 2008, the Food and Drug Administration (FDA) issued a "black box warning" to consumers and health care professionals that a rare but serious form of kidney failure, acute phosphate nephropathy, had been associated with the use of prescription oral sodium phosphate (OSP) products Visicol and Osmo Prep, both made by Salix Pharmaceuticals. The products are routinely prescribed for bowel cleansing prior to colonoscopy, radiographic procedures and surgery. Acute phosphate nephropathy is a rare but serious adverse event that is often permanent and may require chronic dialysis. The FDA expressed equal concern about the risks associated with over-the-counter (OTC) bowel clearing products such as Fleet Phospho-soda and Fleet Accu-Prep solutions.

FDA warned consumers to immediately stop using Hydroxycut products by Iovate Health Sciences, Inc. Hydroxycut products are associated with a number of serious liver injuries. Hydroxycut products are dietary supplements that are marketed for weight-loss, as fat burners, as energy-enhancers, as low carb diet aids, and for water loss under the Iovate and MuscleTech brand names.

On December 11, 2008, the Food and Drug Administration (FDA) issued a "black box warning" to consumers and health care professionals that a rare but serious form of kidney failure, acute phosphate nephropathy, had been associated with the use of prescription oral sodium phosphate (OSP) products Visicol and Osmo Prep, both made by Salix Pharmaceuticals. The FDA expressed equal concern about the risks associated with over-the-counter (OTC) bowel clearing products such as Fleet Phospho-soda and Fleet Accu-Prep solutions.

Colon cleansing. It's a popular health trend. But a recent Food and Drug Administration (FDA) announcement urges cleansers to steer clear of OTC laxatives as a way to bowel cleanse.

In response to the Food and Drug Administration's stern safety warning last December about the risk of a rare form of kidney failure associated with two oral sodium phosphate medicines prescribed to cleanse the colon prior to a colonoscopy, C.B. Fleet Company Inc. announced a voluntary recall of its over-the-counter Fleet Phospho-soda and Fleet Phospho-soda EZ-Prep Bowel Cleansing System.

The FDA announced that ION Labs has issued a voluntary recall of all Influend Cough and Cold products in Alabama, sold on or after May 30, 2008. The recalled products did not meet proper testing specifications and may have a possibility to be super-potent, posing possible health risks.

Many times when our skilled team of professional investigators takes a look at a personal injury claim, they find a defective product is to blame. This is especially true in the case of workers injured on the job. What might initially appear to be a worker’s compensation claim might turn out to be a case involving a dangerous product or piece of equipment, about which employers should have been aware. In this article, Beasley Allen attorney Kendall Dunson discusses a case where a man working at a log processing facility lost his leg to defective equipment used to feed the logs through the process.

All Yamaha Rhino 450 and 660 model vehicles were recalled for repairs designed to prevent accidents that resulted in 46 deaths and hundreds of injuries. The reported deaths occurred between the fall of 2003, when the vehicles were first distributed, through this year.